APA (7th ed.) Citation

Miura, K., Nakano, H., Sakurai, J., Kobayashi, S., Koizumi, S., Arai, T., . . . Koike, J. (2011). Splenomegaly in FOLFOX-naive stage IV or recurrent colorectal cancer patients due to chemotherapy-associated hepatotoxicity can be predicted by the aspartate aminotransferase to platelet ratio before chemotherapy. International journal of clinical oncology, 16(3), 257-263. https://doi.org/10.1007/s10147-010-0176-0

Chicago Style (17th ed.) Citation

Miura, Kazuhiro, et al. "Splenomegaly in FOLFOX-naive Stage IV or Recurrent Colorectal Cancer Patients Due to Chemotherapy-associated Hepatotoxicity Can Be Predicted by the Aspartate Aminotransferase to Platelet Ratio Before Chemotherapy." International Journal of Clinical Oncology 16, no. 3 (2011): 257-263. https://doi.org/10.1007/s10147-010-0176-0.

MLA (9th ed.) Citation

Miura, Kazuhiro, et al. "Splenomegaly in FOLFOX-naive Stage IV or Recurrent Colorectal Cancer Patients Due to Chemotherapy-associated Hepatotoxicity Can Be Predicted by the Aspartate Aminotransferase to Platelet Ratio Before Chemotherapy." International Journal of Clinical Oncology, vol. 16, no. 3, 2011, pp. 257-263, https://doi.org/10.1007/s10147-010-0176-0.